Actively Recruiting
PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry
Led by University Hospital, Ghent · Updated on 2024-12-09
120
Participants Needed
3
Research Sites
519 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this multicentric registry is to gather data from trainees completing PROSPECT: a PROficiency Based StePwise Endovascular Curricular Training to obtain basic cognitive and technical skills. The main goals are to identify if: * Results from a previous randomised controlled trail can be reproduced in real life. * Evaluate skills retention after program completion. * Assess real life implementation of the training program.
CONDITIONS
Official Title
PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Surgical trainee
- Knowledge and technical skill level evaluated
- Demographics questionnaire and general MCQ test completed
- Endovascular simulated exercise completed after familiarization with the simulator
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University Hospital Ghent
Ghent, Belgium, 9000
Actively Recruiting
2
KU Leuven
Leuven, Belgium, 3000
Actively Recruiting
3
CAMES
Copenhagen, Denmark, 2100
Actively Recruiting
Research Team
I
Isabelle Van Herzeele, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here